Home
Bios Fund II QP, 10% Owner: Lantern Pharma LTRN Sell · Filed 24/05/28
Trade details
- Type
- Insider sale
- Amount
- $87,911.04
- Shares · price
- 13,888 sh · $6.33 a share
- Held after
- 429,286 sh
- Stock
- Lantern Pharma LTRN
- Person
- Bios Fund II QP10% Owner
- Trade date
- 24/05/24
- Filed
- 24/05/28
- Days to filing
- 4 days
Sold 3.1% of holdings
- Share of holding sold
- 3.1%
Lantern Pharma trades, last 26 weeks
What else happened in Lantern Pharma around then
Filed or reported within 30 days of the trade day · 24/04/24~24/06/23Bios Fund II QP's recent trades
- Bios Fund II QP
BuyActuate Therapeutics
BuyActuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
- Bios Fund II QP
SellLantern Pharma
SellLantern Pharma
LTRN
$43.9K
14,218 sh
$43.9K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II QP
SellLantern Pharma
SellLantern Pharma
LTRN
$38.1K
12,319 sh
$38.1K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II QP
SellLantern Pharma
SellLantern Pharma
LTRN
$22.3K
7,206 sh
$22.3K
Filed 25/06/13
Traded 25/06/13
- Bios Fund II QP
SellLantern Pharma
SellLantern Pharma
LTRN
$13.5K
4,354 sh
$13.5K
Filed 25/06/13
Traded 25/06/13
